Takeda Pharmaceutical
TAK
#422
Rank
C$80.42 B
Marketcap
C$25.46
Share price
-0.21%
Change (1 day)
27.01%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2025 (TTM): C$4.49 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are C$29.86 Billion. , an increase over its 2024 earnings that were of C$3.05 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2025

Annual earnings

Year Earnings Change
2025 C$4.54 B49.03%
2024 C$3.05 B-2.41%
2023 C$3.12 B-28.14%
2022 C$4.35 B-40.9%
2021 C$7.36 B78.24%
2020 C$4.13 B246.1%
2019 C$1.19 B-48.79%
2018 C$2.33 B-23.64%
2017 C$3.05 B21.7%
2016 C$2.50 B-253.01%
2015 -C$1.64 Billion-159.65%
2014 C$2.74 B13%
2013 C$2.43 B2.46%
2012 C$2.37 B-57.05%
2011 C$5.52 B-10.49%
2010 C$6.17 B-3.99%
2009 C$6.43 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$44.31 B 874.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.36 B 391.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$16.21 B 256.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$11.27 B 147.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$12.44 B 173.64%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$31.58 B 594.30%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$12.75 B 180.33%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-C$1.09 Billion-123.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
C$1.19 B-73.74%๐Ÿ‡ฎ๐Ÿ‡ณ India